Eversept Partners, LP

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1697013 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,335,712

+$188,407 QoQ

Shares Held

275,471

-3.6% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#51

of 197 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. NAMS ranks #23 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	913,880	$121,783,648
2	VERA	Vera Therapeutics, Inc.	2,212,770	$94,949,960
3	CLDX	Celldex Therapeutics, Inc.	1,785,941	$66,454,864
4	SNDX	Syndax Pharmaceuticals Inc	2,798,210	$61,168,870
5	IONS	Ionis Pharmaceuticals Inc	664,684	$52,702,794
6	TVTX	Travere Therapeutics, Inc.	798,973	$45,389,656
7	PCVX	Vaxcyte, Inc.	629,952	$36,619,109
8	GERN	Geron Corp	18,717,422	$23,958,300

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,335,712	275,471	-3.6%	Shares	Sole	2026-08-14
2026-03-31	$9,147,305	285,764	-32.1%	Shares	Sole	2026-05-15
2025-12-31	$14,762,611	420,827	-13.9%	Shares	Sole	2026-02-17
2025-09-30	$13,895,556	488,592	+17.9%	Shares	Sole	2025-11-14
2025-06-30	$7,505,327	414,430	+47.5%	Shares	Sole	2025-08-14
2025-03-31	$5,751,066	280,951	+2.0%	Shares	Sole	2025-05-15
2024-12-31	$7,076,803	275,362	-10.4%	Shares	Sole	2025-02-14
2024-09-30	$5,102,126	307,357	-6.8%	Shares	Sole	2024-11-14
2024-06-30	$6,337,186	329,890	-6.8%	Shares	Sole	2024-08-14
2024-03-31	$8,371,272	353,965	-5.5%	Shares	Sole	2024-05-15
2023-12-31	$4,182,092	374,404	-43.3%	Shares	Sole	2024-02-14
2023-09-30	$6,110,716	660,618	-4.6%	Shares	Sole	2023-11-14
2023-06-30	$8,232,267	692,369	+1409.9%	Shares	Sole	2023-11-08
2023-03-31	$608,050	45,856	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.